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Background. Disparities in coronavirus disease 2019 (COVID-19) testing—the pandemic’s most critical but limited resource—
may be an important but modifiable driver of COVID-19 inequities.
Methods. We analyzed data from the Missouri State Department of Health and Senior Services on all COVID-19 tests conducted in the St Louis and Kansas City regions. We adapted a well-established tool for measuring inequity—the Lorenz curve—to
compare COVID-19 testing rates per diagnosed case among Black and White populations.
Results. Between 14/3/2020 and 15/9/2020, 606 725 and 328 204 COVID-19 tests were conducted in the St Louis and Kansas
City regions, respectively. Over time, Black individuals consistently had approximately half the rate of testing per case than White
individuals. In the early period (14/3/2020 to 15/6/2020), zip codes in the lowest quartile of testing rates accounted for only 12.1%
and 8.8% of all tests in the St Louis and Kansas City regions, respectively, even though they accounted for 25% of all cases in each
region. These zip codes had higher proportions of residents who were Black, without insurance, and with lower median incomes.
These disparities were reduced but still persisted during later phases of the pandemic (16/6/2020 to 15/9/2020). Last, even within the
same zip code, Black residents had lower rates of tests per case than White residents.
Conclusions. Black populations had consistently lower COVID-19 testing rates per diagnosed case than White populations in 2
Missouri regions. Public health strategies should proactively focus on addressing equity gaps in COVID-19 testing to improve equity
of the overall response.
Keywords. COVID-19 testing; racial disparities; Lorenz curve; inequity; structural racism.
The impact of the coronavirus disease 2019 (COVID-19) pandemic has mirrored existing racial health disparities in the
United States [1–4] and, even if not entirely unsurprising, demands additional explanation and urgent remedy. Over the last
6 months, epidemiologic studies have repeatedly shown greater
burden of COVID-19 cases, hospitalizations, and mortality in
minority communities [2–8]. This disparate impact likely results, in part, from social and economic inequities deeply embedded in American society. For example, overrepresentation
of minorities in lower-wage service and essential occupations
means greater exposure risks and less access to protective
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measures (eg, no guaranteed sick leave) for many Black individuals. However, better understanding of the contribution of
health systems behavior to COVID-19 disparities [4–10] can
reveal immediately modifiable mechanisms and redirect ongoing public health efforts.
COVID-19 testing, in particular, is one of the most essential
components of an effective COVID-19 public health response
and represents an important potential mechanism for disparities [1, 2]. Adequate testing is essential for epidemic control
as it facilitates early case detection, self-isolation, and prevention of onward transmission [11–16]. Furthermore, it enables
accurate recognition of disease burden in communities, thereby
contributing to appropriate responses from both the public
health system and individuals (eg, mask wearing and social
distancing) [17]. Although inequitable COVID-19 testing in already marginalized populations can magnify their risk for poor
outcomes, few studies have examined the extent of disparities
in COVID-19 testing [11–14, 18, 19] relative to the burden of
disease.
We seek to deepen our understanding of health disparities
in COVID-19 testing by examining testing equities explicitly in
relation to disease burden over time and geography in the St
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Understanding Drivers of Coronavirus Disease 2019
(COVID-19) Racial Disparities: A Population-Level Analysis
of COVID-19 Testing Among Black and White Populations

METHODS
Study Setting and Data

We sought to assess disparities in COVID-19 testing across 7
counties in the St Louis region (St Louis City, St Louis County, St
Charles, Jefferson, Franklin, Lincoln, and Warren) and 4 counties in the Kansas City region (Jackson, Clay, Cass, and Platte).
We used data from the Missouri State Department of Health
and Senior Services on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) polymerase chain reaction (PCR) or
antigen tests conducted in Missouri. This is expected to contain
near-complete data on all tests performed in the state, as reporting was mandated. This dataset contains test date, test type,
test result, performing laboratory, patient age category, race, and
zip code. We used data from the 2018 American Community
Surveys to obtain sociodemographic and socioeconomic characteristics of individual zip codes.
Analyses

Our analyses are based on the premise that an equitable testing
strategy is defined by a relative balance between the number
of tests done and the overall disease burden in a community,
rather than simply an equal number of tests done per person (ie,
equal testing). Decreased testing rates relative to the number of
cases identified generally indicates that testing is only occurring
among symptomatic patients with a higher probability of disease. In contrast, higher test rates per case indicates testing is
sufficiently widespread to be effective at also capturing asymptomatic and mild cases of COVID-19, which are a major driver
of the pandemic [11–15, 21]. The World Health Organization
(WHO) suggests that adequate testing levels are indicated by at
least 10, and ideally 30, tests for every diagnosed case [11–15].
Based on these principles, we sought to assess disparities in
COVID-19 testing and disease burden in several ways.
First, we estimated new COVID-19 tests and cases per day
and the rate of COVID-19 testing per diagnosed case among
Black and White individuals over time.
Second, we generated modified versions of Lorenz curves
to assess the relative equity in the distribution of COVID-19
testing and disease burden across zip codes. Lorenz curves—
originally developed by economists to graphically represent
income equality—have more recently been leveraged as a tool
for public health [20, 22, 23]. A Lorenz curve is generated by
plotting the cumulative proportion of the total population
e2922 • cid 2021:73 (1 November) • Mody et al

against the cumulative proportion of a resource or burden of
disease after sorting values in ascending order. If the resource or
burden is equitably distributed across the population, the curve
will follow a straight line at a 45-degree angle. The curve becomes more convex with increasing inequity. We adapted this
method to examine disparities in (1) the number of COVID-19
tests performed relative to the burden of diagnosed COVID19 cases and (2) the gap between existing and adequate testing
levels, which we define as the number of additional negative
tests needed to achieve 20 tests per diagnosed case (based on
WHO guidance) [14, 24, 25]. We used zip codes as the unit
of analysis and generated Lorenz curves for both the early (14
March to 15 June) and later (16 June to 15 September) phases of
the pandemic. We also calculated Gini coefficients—a measure
of equality/inequality between 0 and 1, with 0 indicating perfect equality and 1 indicating perfect inequality—and Hoover
indices—a metric that indicates what percentage of the resource
would need to be reallocated in order to achieve an equitable
distribution [26]. Last, we grouped zip codes into quartiles
based on their position on Lorenz curves and assessed differences in zip code–level sociodemographic and socioeconomic
characteristics using Kruskal-Wallis tests.
Third, we generated bubble plots to compare rates of COVID19 testing for Black versus White residents living in the same
zip code. For this analysis, we only considered zip codes whose
populations were at least 1% Black and 1% White to avoid
identifying extreme outliers from small denominators.
Last, we performed univariate and multivariable mixedeffects Poisson regression to identify individual-level (eg, race,
age) and zip code–level (eg, racial makeup, health insurance
coverage) factors independently associated with having a positive COVID-19 test. Zip code was included as random effect. We also assessed for an interaction between race and age,
stratifying by time period. The effect of race and racism on
health outcomes is mediated by (as opposed to confounded by)
ecological structural factors such socioeconomic status; thus,
unadjusted analyses assess the overall association with race
and racism while adjusted analyses can be thought to assess the
contribution of systemic racism that still remains even when
adjusting away the mediating effects of the measured ecological factors [1, 2, 27].
To account for missingness in race, patient zip code, and age
variables, we performed multiple imputation using multivariate
normal imputation methods (n = 50 imputations) and adaptive rounding of categorical variables [28–30]. Missingness was
highly dependent on the test date, test result, and performing
laboratory, and thus the missing-at-random assumption (ie,
that missingness was random conditional on all the variables
included in the imputation model [test date, test result, performing laboratory, race, zip code, age, and mortality]) required for unbiased imputation was very plausible in our setting
[28–30].
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Louis and Kansas City regions in Missouri. We used, in part, a
tool from economics—the Lorenz curve—which is commonly
used to visualize and quantify wealth- and income-based inequality in a population [20]. This novel application of an established methodology will enable quantification of the underlying
inequities in COVID-19 testing to directly inform health policy
solutions [20].

Overall

99 439 (10.7)
354 350 (38.0)
209 438 (22.5)
101 007 (10.8)
59 529 (6.4)
49 557 (5.3)
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Died, n (%)

83 879 (10.1)
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…

6440 (1.2)

10 913 (2.1)

23 837 (4.6)
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…
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…

…

442 (0.1)

25 666 (7.8)

3011 (0.9)
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2 (1, 4) (n = 326 116)

16 332 (11.3)

98 538 (68.2)

29 718 (20.6)

12 515 (3.8)

18 557 (5.7)

34 524 (10.6)

72 822 (22.3)

135 663 (41.5)

35 595 (10.9)

17 321 (5.3)

328 204

Kansas City

Abbreviations: COVID-19, coronavirus disease 2019; IQR, interquartile range.
a
Overall missing values: Age category, 2859; Race, 545 816; Median days from testing to results, 5736; County, 106 025.

210 056 (22.5)

14 March–15 June

Time period, n (%)

219 364 (26.5)

  Jackson

Kansas City region

26 1075 (31.5)

  St Louis

St Louis region

County,a n (%)

2 (2, 5) (n = 929 193)

Median (IQR) days from testing to resultsa
3 (2, 5) (n = 603 077)

273 058 (70.2)

Other

174 520 (71.4)

89 695 (23.1)

Black

59 977 (24.5)

37 042 (6.1)

40 972 (6.8)

66 483 (11.0)

136 616 (22.6)

218 687 (36.1)

63 844 (10.6)

41 429 (6.8)

606 725

White

Race,a n (%)

58 750 (6.3)

18–24 years

934 929

0–17 years

Age category,a n (%)

Number of tests

Table 1.  Characteristics of COVID-19 Testing
Black

65 283 (72.8)

24 412 (27.2)

770 (0.9)

511 (0.6)

1915 (2.2)

26 298 (30.2)

79 (0.1)

157 (0.2)

114 (0.1)

283 (0.3)

2461 (2.8)

18 873 (21.7)

35 533 (40.8)

696 (0.8)

15 916 (17.7)

1196 (1.3)

4120 (4.6)

2 (1, 3) (n = 89 461)

…

…

…

2364 (2.6)

4600 (5.1)

10 316 (11.5)

23 137 (25.9)

34 339 (38.4)

8224 (9.2)

6524 (7.3)

89 695

White

215 104 (78.8)

57 954 (21.2)

7595 (2.9)

7674 (2.9)

17 258 (6.5)

64 523 (24.5)

2719 (1.0)

4961 (1.9)

11 419 (4.3)

22 144 (8.4)

32 665 (12.4)

16 085 (6.1)

76 790 (29.1)

1168 (0.4)

29 841 (10.9)

2820 (1.0)

12 043 (4.4)

2 (1, 3) (n = 272 240)

…

…

…

15 773 (5.8)

24 388 (9.0)

38 533 (14.2)

63 503 (23.3)

85 619 (31.5)

25 081 (9.2)

19 251 (7.1)

273 058

…

…

5868 (3.2)

4699 (2.6)

13 504 (7.4)

45 502 (24.8)

1150 (0.6)

2131 (1.2)

4997 (2.7)

9908 (5.4)

18 972 (10.4)

20 458 (11.2)

56 091 (30.6)

1291 (0.6)

15 671 (7.5)

2429 (1.2)

21 435 (10.2)

3 (2, 7) (n = 20 7557)

5584 (6.3)

57 954 (65.9)

24 412 (27.8)

12 582 (6.0)

17 180 (8.2)

29 167 (13.9)

53 486 (25.6)

74 230 (35.5)

13 805 (6.6)

8844 (4.2)

210 056

14 March–15 June
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…

…

14 537 (2.3)

17 074 (2.6)

32 645 (5.1)

173 862 (26.9)

5290 (0.8)

8782 (1.4)

18 840 (2.9)

38 721 (6.0)

67 468 (10.5)

63 421 (9.8)

204 984 (31.7)

749 (0.1)

57 891 (8.0)

2397 (0.3)

72 633 (10.0)

2 (2, 4) (n = 721 636)

20 776 (6.9)

215 104 (71.4)

65 283 (21.7)

36 975 (5.1)

42 349 (5.9)

71 840 (9.9)

155 952 (21.6)

280 120 (38.8)

85 634 (11.8)

49 906 (6.9)

724 873

16 June–15 September

All analyses were conducted using Stata MP 16.1 (StataCorp)
and R 3.2.4 (R Foundation for Statistical Computing). P values
less than or equal to .05 were considered statistically significant.
RESULTS

COVID-19 Testing Disparities Over Time

In both regions, the number of COVID-19 tests per diagnosed
case steadily increased until mid-June but began to decline after
a new surge in cases beginning in mid-July (Figure 1). The rate
of tests per case in the Black population consistently remained
about half that of the White population until August. Even
though the overall number of tests expanded steadily over time,

COVID-19 Testing Disparities Across Zip Codes Using Lorenz Curves

Modified Lorenz curves depict the distribution of COVID-19
testing with respect to the number of diagnosed cases across
zip codes (Figure 2, Table 2). Between 14 March and 15 June,
zip codes in the quartile with the lowest rates of tests per case
accounted for only 12.1% and 8.8% of all tests in the St Louis
and Kansas City regions, respectively, but accounted for 25%
of all cases in each region. These zip codes had higher proportions of Black residents, lower median incomes, higher rates of
poverty, lower rates of health insurance coverage, a higher proportion of residents employed in the service sector, and a higher
proportion of public transport users (Figure 2, Supplementary
Tables 3 and 4). In contrast, zip codes with the highest rates
of testing per case accounted for 45.3% and 45.2% of all tests,
respectively, to diagnose a similar number of cases (ie, 25% of
cases in the region). These zip codes tended to have a lower
percentage of Black residents and be more socioeconomically

Figure 1.
A–D, Number of COVID-19 tests, diagnosed cases, and tests per diagnosed case ratio among Black and White individuals over time. Estimates represent 7-day
moving averages derived from multiply imputed datasets. Abbreviation: COVID-19, coronavirus disease 2019.
e2924 • cid 2021:73 (1 November) • Mody et al
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Between 14 March 2020 and 15 September 2020, 606 725 total
COVID-19 tests were conducted across 7 counties in the St
Louis region (total population, 2 135 730: 19.2% Black, 74.6%
White) and 328 204 were conducted across 4 counties in the
Kansas City region (total population, 1 292 263: 15.1% Black,
76.5% White) (Table 1, Supplementary Tables 1 and 2).

it increased more rapidly among the White population as opposed to the Black population (Figure 1).

advantaged (Figure 2, Supplementary Tables 3 and 4). Disparity
patterns were similar although more extreme when considering
the gap in testing to reach adequate levels across zip codes (ie,
how many additional tests would be needed to achieve 20 tests
per case) (Figure 2, Supplementary Tables 5 and 6).
In contrast to the earlier period, disparities in testing relative
to cases were less apparent between 16 June and 15 September
(Figure 2, Supplementary Tables 3–6). When tracking Gini
coefficients over time, levels of testing disparities began to
decline in mid-June, corresponding to a more rapid increase

in cases in the White as compared with the Black population
(Figure 3).
COVID-19 Testing Disparities Within Zip Codes

Black individuals also had consistently lower rates of COVID19 testing per case compared with White individuals residing
in the same zip codes (Figure 4). This pattern was largely irrespective of the overall racial makeup of a zip code (ie, whether
the zip codes were predominantly White or Black). Only 13 of
173 zip codes had a testing rate of greater than 20 tests per case

Table 2.   Gini Coefficients and Hoover Indices by Region and Time Period
Gini Coefficient
14 March–15 June

Hoover Index

16 June–15 September

14 March–15 June

16 June–15 September

St Louis
Tests per case

0.281

0.110

0.203

0.076

Testing gap over population

0.619

0.243

0.471

0.165

Kansas City
Tests per case

0.316

0.176

0.222

0.120

Testing gap over population

0.861

0.396

0.699

0.266
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Figure 2.
Lorenz curves of disparities in COVID-19 testing. This figure depicts modified Lorenz curves examining disparities in COVID-19 testing. The units of analysis are
zip codes and they are color-coded by their overall racial makeup. Separate curves were generated for the periods between 14 March to 15 June and 16 June to 15 September.
The dashed line represents equitable distribution where 50% of testing would be conducted in zip codes accounting for 50% of hospitalizations. Panels A and C depict Lorenz
curves for the St Louis and Kansas City regions, respectively, measuring disparities in the distribution of COVID-19 tests relative to the diagnosed cases in a zip code. Panels
B and D depict Lorenz curves for St Louis and Kansas City, respectively, examining the current gap in COVID-19 tests (ie, the number of additional negative tests needed to
achieve 30 tests per diagnosed case) relative to the total population in a zip code. Abbreviation: COVID-19, coronavirus disease 2019.

among Black residents, but 30 zip codes had this rate among its
White residents.
Factors Associated With a Having Positive COVID-19 Test

In multivariable mixed-effects Poisson regression, Black
race was one of the strongest factors associated with testing
positive for COVID-19 (adjusted risk ratio [aRR], 1.60; 95%
confidence interval [CI], 1.52–1.69) (Table 3). Additional
risk factors included being 18 to 24 years old (aRR, 1.37;
95% CI, 1.31–1.44) as compared to age 24–49 and residing
in a zip code with lower levels of insurance coverage (aRR,
1.15 per 10% increase in the uninsured; 95% CI, 1.04–1.26).
In assessing interactions between race and age across time
periods, Black race was consistently associated with lower
rates of testing per case across age strata and time periods but
these were lowest for older Black individuals in the earlier
phases of the pandemic (P < .001 for interaction for both
periods) (Figure 5).
DISCUSSION

Our analyses revealed consistent disparities in the rates of
COVID-19 testing relative to COVID-19 disease burden between Black and White communities over time, across both the
St Louis and Kansas City regions of Missouri, across zip codes
within these regions, and even within zip codes. Overall, these
results highlight the systemic inequities in one of the most
e2926 • cid 2021:73 (1 November) • Mody et al

critical but limited resources for controlling the COVID-19
pandemic but one that is immediately actionable: COVID-19
testing.
A key premise of our analysis is that an equitable testing
strategy is essential for a successful COVID-19 response and
requires that testing be scaled up in proportion to the disease
burden in an area, which is also in line with current WHO guidance [14, 24, 25]. Increases in the overall disease burden also
affect this metric, but public health programs failing to adapt
testing to meet this threshold will still run the risk of identifying
only the most severe and symptomatic cases in a community
while systematically missing more mild and asymptomatic
cases. This ultimately has immense implications for disease control as transmission from asymptomatic individuals is a major
driver of the pandemic [11–15, 21]. We find that, although the
burden of COVID-19 disease has disproportionately affected
Black communities more, rates of COVID-19 testing have also
not been correspondingly scaled up relative to this increased
disease burden. This finding remained consistent over time,
across regions, and even within geographical areas.
First, despite overall expansion of testing, rates of COVID-19
tests per case among Black individuals consistently remained half
that of White individuals for most of the pandemic, a finding
that has also been demonstrated in other regions of the country
[13, 18, 19]. Moreover, overall testing numbers actually increased
more rapidly among White compared with Black individuals,

Downloaded from https://academic.oup.com/cid/article/73/9/e2921/6033727 by Washington University School of Medicine Library user on 29 April 2022

Figure 3.
Temporal trends in COVID-19 testing disparities. This figure depicts trends in the Gini coefficients for 2 metrics over time in the St Louis and Kansas City regions: (1) COVID testing relative to diagnosed cases (solid line) and (2) gap in COVID-19 testing (ie, the number of additional negative tests needed to achieve 30 tests per
diagnosed case) (dashed line). Gini coefficients were calculated on a biweekly basis from Lorenz curves generated for that time interval. Abbreviation: COVID-19, coronavirus
disease 2019.

with testing in Black populations always being far from the
target necessary for optimizing infection control. Although disparities were reduced in later phases of the pandemic, this was

driven more by increased case counts among the White population rather than any increased testing in the Black population.
Second, using modified Lorenz curves, the majority of zip codes

Racial Disparities in COVID-19 Testing • cid 2021:73 (1 November) • e2927
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Figure 4.
Disparities in COVID-19 testing among Black and White residents of the same zip code. This figure depicts testing rates per diagnosed case (A) and the gap in
negative COVID-19 tests to reach 20 tests per case (B) in Black versus White residents of the same zip code. Each marker represents a single zip code in either the St Louis
(bubble) or Kansas City (diamond) region. Markers are color-coded by the racial makeup of the zip code and sized by the absolute value of metric of interest (ie, rate of COVID19 tests per case in panel A and the overall number of negative COVID-19 tests needed in panel B). The dashed line represents equitable testing distribution between Black
and White residents. Zip codes falling above the dashed line in panel A or below it in panel B indicate that they decreased testing in Black as opposed to White residents
(and vice versa). Abbreviation: COVID-19, coronavirus disease 2019.

Table 3.   Mixed-Effects Poisson Model of Individual- and Zip Code–Level Factors Associated With Having a Positive COVID-19 Test
Unadjusted Risk Ratio (95% CI)

P

Adjusted Risk Ratio (95% CI)

P

Race
Black

1.55 (1.52–1.58)

White

1 (ref)

<.001

1.60 (1.52–1.69)
1 (ref)

Other

1.38 (1.33–1.42)

1.36 (1.29–1.43)

<.001

<18 years

1.03 (1.00–1.06)

18–24 years

1.35 (1.32–1.37)

1.37 (1.31–1.44)

25–49 years

1 (ref)

1 (ref)

50–64 years

.88 (.86–.89)

.87 (.84–.89)

65–74 years

.73 (.71–.75)

.74 (.70–.78)

75–84 years

.82 (.80–.85)

.87 (.81–.94)

≥85 years

.85 (.82–.88)

Long-term-care resident

.78 (.75–.80)

<.001

.99 (.94–1.03)

<.001

.97 (.87–1.08)
<.001

.79 (.66–.94)

.009

Zip code–level characteristics
Percent Black, per 10% increase

1.00 (1.00–1.00)

.176

.98 (.96–1.00)

.023

Total population, per 10 000 increase

1.02 (1.01–1.02)

<.001

1.03 (1.01–1.05)

.006

Average household size, per 1 person increase

1.00 (1.00–1.00)

.03

1.00 (1.00–1.00)

.774

Median income, per $10 000 increase

1.00 (1.00–1.00)

.013

1.00 (1.00–1.00)

.465

Percent below poverty line, per 10% increase

1.00 (1.00–1.00)

.03

…a

…a

Percent without health insurance, per 10% increase

1.22 (1.20–1.23)

<.001

1.15 (1.04–1.26)

.006

Percent in healthcare industry, per 10% increase

1.00 (1.00–1.00)

.086

1.00 (1.00–1.00)

.765

Percent in service industry, per 10% increase

1.00 (1.00–1.00)

.176

…a

…a

1 (ref)

.003

Region
St Louis

1 (ref)

Kansas City

.91 (.89–.92)

<.001

.89 (.82–.96)

Time period
14 March–15 June

1 (ref)

16 June–15 September

1.05 (1.03–1.07)

<.001

1 (ref)

.297

1.06 (.95–1.17)

Abbreviations: CI, confidence interval; COVID-19, coronavirus disease 2019; ref, reference value.
a

Excluded from multivariable model due to collinearity.

with a higher proportion of Black residents and lower health
insurance coverage also had the lowest rates of testing per case
and higher gaps between existing and adequate levels of testing
as opposed to the zip codes with higher rates of testing, which
were overwhelmingly White. Third, Black residents were more
likely to have lower rates of tests per case even compared with
White residents within the same zip code and this was irrespective of the overall racial makeup of that zip code level. Last, even
in models adjusting for differences in individual-level characteristics and mediation of ecologic zip code–level characteristics,
being Black was associated with a higher risk of testing positive
for COVID-19 and thus having lower rates of tests per case. The
lowest testing rates occurred in the most at-risk group: older
Black individuals in the early pandemic phases when there was
less knowledge about transmission prevention, limited access to
testing, and no evidence-based treatments. Thus, our analyses
demonstrate a pattern of COVID-19 testing disparities that, although changing, was pervasive regardless of time or geography
and reflects aspects of both structurally and individually mediated racism [1]. Ultimately, these disparities may also be an important driver of the disparities in actual disease burden, a point
of national concern.
e2928 • cid 2021:73 (1 November) • Mody et al

The underlying etiologies for these consistent disparities in
COVID-19 testing are likely severalfold, but, ultimately, are all
manifestations of structural racism in our healthcare system
and current society [1–4]. It is thus to be expected that these existing structural disparities in healthcare have permeated into
the COVID-19 response as well [11, 12] and have only been exacerbated through mechanisms such as access to testing sites or
funding allocation during the pandemic [31–35]. For example,
North St Louis, a predominantly Black community that was one
of the hardest hit in Missouri, did not have a single testing site
several weeks into the pandemic [35]. It is also important to acknowledge that years of experience with structural racism in a
historically discriminatory healthcare system has also garnered
a significant yet appropriate level of mistrust of the healthcare
system, which may lead those in Black communities to have
a higher threshold for seeking out testing [4]. These potential
drivers of testing disparities are layered onto the inequities that
have led to an increased burden of disease in Black communities, which includes higher proportions of essential workers,
less paid sick leave, lower ability to work from home, and living
in more crowded settings and multigenerational households
[4–6, 10].

Downloaded from https://academic.oup.com/cid/article/73/9/e2921/6033727 by Washington University School of Medicine Library user on 29 April 2022

Age category

Addressing inequities in testing is an immediately actionable
target in the short term but will likely require implementing
proactive public health responses that move beyond the existing healthcare infrastructure to increase testing access. Our
analyses show that, to date, there has been limited evidence of
any adaptive or targeted strategies to increase testing in areas
with a higher burden of disease. Going forward, however, it is
essential for public health officials to consider more deliberate
and targeted strategies. Targeted community-based testing campaigns in venues such as community centers and high-density
residential spaces such as public housing, places of worship, or

transportation hubs could improve access to testing, particularly
in communities that have suffered neglect by existing public
health infrastructures to date [11, 12]. Saliva-based COVID-19
tests, which can easily be administered on a large scale, can make
community-based testing campaigns significantly more feasible
[36, 37]. Community-based approaches will also be essential
for ensuring equitable access to COVID-19 vaccines once they
are available. In designing these efforts, it is essential that public
health officials actively engage the individual communities
themselves in developing plans that take into account the layered
levels of trauma that exist in these communities [3, 4]. Focusing
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Figure 5.
A, B, Adjusted age-stratified estimates of COVID-19 tests per diagnosed case. This figure represents age-stratified estimates of COVID-19 testing per case
in models adjusted for differences in zip code–level characteristics. Estimates based on mixed-effects Poisson regression stratified by time period assessing an interaction
between race and age and adjusted for long-term-care residency status, zip code–level characteristics, and region. For both periods, the P value for the interaction between
race and age strata was <.001. Abbreviation: COVID-19, coronavirus disease 2019.
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disparities over time. COVID-19 testing is critical to an effective pandemic response, and these testing inequities may be
one of the important drivers of the disproportionate impact
of COVID-19 on minority communities in the United States.
Further efforts should focus on proactive public health strategies to specifically address equity gaps in COVID-19 testing in
order to improve the equity of the overall COVID-19 response.
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